Impact of DRG billing system on health budget consumption in percutaneous treatment of mitral valve regurgitation in heart failure

References

• Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace 2011;13(2 Suppl 2):ii13-ii17
   PubMedGoogle Scholar
• Kaul P, Reed SD, Hernandez AF, et al. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States. JACC Heart Fail 2013;1:523-30
   Google Scholar
• Reed SD, Kaul P, Li Y, et al. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF. J Card Fail 2013;19:611-20
   PubMed Web of Science ®Google Scholar
• Carmona M, Garcia-Olmos LM, Garcia-Sagredo P, et al. Heart failure in primary care: co-morbidity and utilization of health care resources. Fam Pract 2013;30:520-4
   PubMed Web of Science ®Google Scholar
• Li Y, Levy WC, Neilson MP, et al. Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION. J Card Fail 2014;20:541-7
   PubMed Web of Science ®Google Scholar
• Miller G, Cohen JT, Roehrig C. Cost-effectiveness of cardiovascular disease spending. J Am Coll Cardiol 2012;60:2123-4
   PubMed Web of Science ®Google Scholar
• Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43
   PubMed Web of Science ®Google Scholar
• Robbins JD, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2
   PubMed Web of Science ®Google Scholar
• Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail 2005;7:1112-17
   PubMed Web of Science ®Google Scholar
• Varadarajan P, Sharma S, Heywood JT, et al. High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography. J Am Soc Echocardiogr 2006;19:1458-61
   PubMed Web of Science ®Google Scholar
• Tavazzi L, Senni M, Metra M, et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 2013;6:473-81
   PubMed Web of Science ®Google Scholar
• Patel JB, Borgeson DD, Barnes ME, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 2004;10:285-91
   PubMed Web of Science ®Google Scholar
• Supino PG, Borer JS, Yin A, et al. The epidemiology of valvular heart diseases: the problem is growing. Adv Cardiol 2004;41:9-15
   PubMed Web of Science ®Google Scholar
• Aronson D, Goldsher N, Zukermann R, et al. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Arch Intern Med 2006;166:2362-8
   PubMed Web of Science ®Google Scholar
• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96
   PubMed Web of Science ®Google Scholar
• Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 2014;63:185-6
   PubMed Web of Science ®Google Scholar
• Roques F, Michel P, Goldstone AR, et al. The logistic EuroSCORE. Eur Heart J 2003;24:881-2
   PubMed Web of Science ®Google Scholar
• Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-7
   PubMed Web of Science ®Google Scholar
• Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-201
   PubMed Web of Science ®Google Scholar
• Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65
   PubMed Web of Science ®Google Scholar
• Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-9
   PubMed Web of Science ®Google Scholar
• Ussia GP, Barbanti M, Cammalleri V, et al. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention 2011;7:573-9
   PubMedGoogle Scholar
• Conradi L, Treede H, Franzen O, et al. Impact of MitraClip therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg 2011;40:1521-6
   PubMed Web of Science ®Google Scholar
• Franzen O, van der HJ, Baldus S, et al. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76
   PubMed Web of Science ®Google Scholar
• Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406
   PubMed Web of Science ®Google Scholar
• Baldus S, Schillinger W, Franzen O, et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 2012;14:1050-5
   PubMed Web of Science ®Google Scholar
• Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 2014;64:172-81
   PubMed Web of Science ®Google Scholar
• Nickenig G, Estevez-Loureiro R, Franzen O, et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol 2014;64:875-84
   PubMed Web of Science ®Google Scholar
• Mealing S, Feldman T, Eaton J, et al. EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip(R) in patients with severe mitral regurgitation ineligible for conventional repair/replacement surgery. J Med Econ 2013;16:1317-26
   PubMedGoogle Scholar
• Cameron HL, Bernard LM, Garmo VS, et al. A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation. J Med Econ 2014;17:599-615
   PubMedGoogle Scholar
• Janssen MF, Birnie E, Haagsma JA, et al. Comparing the standard EQ-5D three-level system with a five-level version. Value Health 2008;11:275-84
   PubMed Web of Science ®Google Scholar
• Evans C, Tavakoli M, Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal. Health Care Manag Sci 2004;7:43-9
   PubMedGoogle Scholar
• Szende A, Oppe M, Devlin N, eds. EQ-5D value sets: inventory, comparative review and user guide. In: EuroQol Group Monographs. Dordrecht: Springer; 2007
   Google Scholar
• Levy WC. Seattle Heart Failure Model. Am J Cardiol 2013;111:1235
   PubMed Web of Science ®Google Scholar
• Palmieri V, Pezzullo S, Lubrano V, et al. [Home-based telemonitoring of simple vital signs to reduce hospitalization in heart failure patients: real-world data from a community-based hospital]. G Ital Cardiol (Rome) 2011;12:829-36
   PubMedGoogle Scholar
• Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 2013;62:317-28
   PubMed Web of Science ®Google Scholar
• Glower D, Ailawadi G, Argenziano M, et al. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg 2012;143:S60-3
   PubMed Web of Science ®Google Scholar
• Rudolph V, Knap M, Franzen O, et al. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 2011;58:2190-5
   PubMed Web of Science ®Google Scholar
• Osnabrugge RL, Speir AM, Head SJ, et al. Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg 2013;96:500-6
   PubMed Web of Science ®Google Scholar
• Neuss M, Schau T, Schoepp M, et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail 2013;15:786-95
   PubMed Web of Science ®Google Scholar
• Cioffi G, Mortara A, Di Lenarda A, et al. Clinical features, and in-hospital and 1-year mortalities of patients with acute heart failure and severe renal dysfunction. Data from the Italian Registry IN-HF Outcome. Int J Cardiol 2013;168:3691-7
   PubMed Web of Science ®Google Scholar